PND12 MODELING THE CLINICAL AND ECONOMIC CONSEQUENCES OF TREATING RELAPSING FORM OF MULTIPLE SCLEROSIS WITH SUBCUTANEOUS VERSUS INTRAMUSCULAR INTERFERON-BETA-IA
Abstract
Authors
S Guo D Copur A Ward JA O'Brien KJ Ishak R Bennett A Al-Sabbah DM Meletiche JJ Caro